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Summary 
We have identified a novel 100 kDa coiled-coil protein, 
rabaptin-5, that specifically interacts with the GTP 
form of the small GTPase Flab& a potent regulator of 
endocytic transport. It is mainly cytosolic, but a frac- 
tion colocalizes with Rab5 to early endosomes. Ex- 
pression of a GTPase-deficient Flab5 mutant enhances 
the binding of rabaptin-5 to enlarged endosomes. Over- 
expression of rabaptin-5 alone is sufficient to promote 
expansion of early endosomes. Rab5 recruits rabap- 
tin-5 to purified early endosomes in a GTP-dependent 
manner, demonstrating functional similarities with 
other members of the Ras superfamily. Immunodeple- 
tion of rabaptin-5 from cytosol strongly inhibits Rab5- 
dependent early endosome fusion. Rabaptin-5 is thus 
a Rab effector required for membrane docking and 
fusion. 
Introduction 
Vesicular transport between organelles is fundamental to 
eukaryotic cell function. Such transport requires high 
specificity and tight regulation in order to deliver cargo 
molecules to the correct acceptor organelle while main- 
taining the integrity of distinct compartments, Owing to 
combined information obtained from yeast genetics, cell- 
free assays, and studies of intact cells and synapses, the 
molecular basis for intracellular transport is beginning to 
emerge (Pryer et al., 1992; Ferro-Novick and Jahn, 1994; 
Rothman, 1994). Interactions between V-SNARES (for ve- 
sicular soluble N-ethylmaleimide-sensitive factor attach- 
ment protein receptors) on the vesicle membrane and 
cognate t-SNARES on the target membrane have been 
proposed to ensure specificity of vesicular transport (SolI- 
ner et al., 1993). Since V-SNARES must be recycled back 
to the donor membrane after having performed their func- 
tion in targeting, the association between SNARE com- 
plexes must be regulated in a directional manner, and, 
consequently, additional molecules must be required to 
ensure specificity in vesicle delivery. 
The Rab family of small GTPases may perform such 
a function. Members of the Rab family regulate defined 
transport steps both in yeast (Novick and Brennwald, 
1993) and mammalian cells (Zerial and Stenmark, 1993; 
Pfeffer, 1994). Like other members of the Ras superfamily, 
Rab proteins cyclically transmit signals to downstream ef- 
fectors in a guanine nucleotide-dependent manner. Con- 
formational differences between their GDP- and GTP- 
bound states determine their interactions with accessory 
molecules. Molecules that control the GDPlGTP cycle of 
Rab proteins (GDPIGTP exchange factors, GEFs, and 
GTPase-activating proteins [GAPS]) have been identified 
or their activity has been detected (Novick and Brennwald, 
1993; Zerial and Stenmark, 1993; Pfeffer, 1994). In con- 
trast, the precise nature of the downstream effecters of 
Rab proteins is still unclear. Recent studies of yeast mu- 
tants suggest that Rab function is required for the forma- 
tion of SNARE complexes (Lian et al., 1994; Segaard et 
al., 1994). However, no direct interaction between the two 
classes of molecules has been demonstrated, and both 
V-SNARES (Dascher et al., 1991) and t-SNARES (Brenn- 
wald et al., 1994) can act as multicopy suppressors of Rab 
mutants in yeast. While genetics in yeast have undoubt- 
edly established that SNARES act downstream of Rab pro- 
teins, it seems unlikely that SNARES serve as direct tar- 
gets for Rab regulation. 
We have been studying the function of RabS, a GTPase 
localized to the plasma membrane, clathrin-coated vesi- 
cles, and early endosomes (Chavrier et al., 1990; Bucci 
et al., 1992). This protein is a rate-limiting component in 
membrane docking or fusion in the early endocytic path- 
way. A GTPase-deficient mutant, Rab5Q79L, stimulates 
endocytosis and early endosome fusion, whereas Rab- 
5S34N, a mutant with preferential affinity for GDP, inhibits 
these processes (Li et al., 1994b; Stenmark et al., 1994a). 
Furthermore, cells expressing Rab5Q79L contain aber- 
rantly large early endosomes, whereas this compartment 
appears fragmented in cells expressing the Rab5S34N 
mutant (Stenmark et al., 1994a). These findings suggest 
that the GTP-bound form of Rab5 is the active conforma- 
tion and mutations that stabilize this structure are pre- 
dicted to favor interactions with target molecules. 
In an attempt to identify such proteins, we have em- 
ployed the Rab5Q79L mutant to screen a cDNA library for 
interacting molecules, using the yeast two-hybrid system 
(Bartel et al., 1993). This screening led to the identification 
of rabaptin-5, a cytosolic protein which is required for the 
function of Rab5 and which associates with Rab5 and early 
endosomes in a GTP-dependent manner. 
Results 
Identification of a Rabblnteracting Protein 
by Two-Hybrid Screening in Yeast 
To identify proteins interacting with the GTP-bound form 
of Rab5, reporter yeast cells were first transformed with 
a plasmid encoding a fusion between Rab5Q79L and the 
bacterial protein LexA, which recognizes specific DNA se- 
quences upstream of the two reporter genes HIS3 and 
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Figure 1. Specific Interaction between Rab5 and Clone Li-46 
HI.93 reporter gene activation caused by specific interactions between 
flab5 and clone Li-46 in the two-hybrid system. L40 reporter yeast 
cells cotransformed with the rescued Ll-46 plasmid and with plasmids 
encoding LexA fusions of the proteins indicated were spotted on syn- 
thetic medrum lacking tryptophan and leucine (left) or lacking trypto- 
phan, leucine, and histidine (right). Colonies were photographed after 
3 days of incubation at 30°C. 
/acZ (Vojtek et al., 1993). The strain was subsequently 
transformed with a plasmid HeLa cell cDNA library encod- 
ing proteins as C-terminal fusions with the transcriptional 
activation domain of Gal4 (Bartel et al., 1993). Library plas- 
mids rescued from positive clones (His3 B-Gal+) were 
transformed into reporter yeast containing various control 
baits. Screening of 4 x 1 O5 transformants yielded six inde- 
pendent clones that interacted strongly with Rab5Q79L, 
but neither with RasGl2V (Vojtek et al., 1993) nor with 
Rab6Q72L (Martinez et al., 1994), GTPase-deficient mu- 
tants of two functionally distinct proteins. The positive 
clones had cDNA inserts ranging from 2.2 kb to 3.4 kb 
and contained identical sequences. The interaction speci- 
ficity of one of these clones, Ll-46, containing a 2.6 kb 
insert, was examined in more detail. 
This clone caused a strong activation of HIS3 in the 
presence of LexA-flab5 and LexA-Rab5Q79L, but not 
in the presence of LexA-Rab5S34N, LexA-RasV12, and 
LexA-Rab6 (Figure 1). For a more quantitative evaluation 
of reporter gene activation, we measured activation of the 
second reporter gene, /acZ, in a liquid 6-galactosidase 
assay (Table 1). LexA-Rab5 caused a strong activation 
of lacZ in the presence of Ll-46. In contrast, there was no 
apparent interaction with Rab6, which controls intra-Golgi 
transport (Martinez et al., 1994). Furthermore, no reporter 
gene activation was detected with LexA fusions of three 
Rab GTPases associated with endocytic structures, Rab4b 
(Bucci and Zerial, unpublished data), Rab17 (LDtcke et 
al., 1993) and Rab22(0lkkonen et al., 1993). Significantly, 
the latter GTPase is the closest relative to Rab5 found so 
far (53% identity), suggesting that the detected interaction 
is highly Rab5-specific. 
Interestingly, the Rab5Q79L mutant caused a 6-fold 
higher reporter gene activation than wild-type Rab5, 
whereas only a very weak /acZ activation was detected 
with the Rab5S34N mutant. Since these two mutants exist 
preferentially in the GTP- and GDP-bound forms, respec- 
tively (Stenmark et al., 1994a), we conclude that the Ll-46 
protein preferentially recognizes Rab5 in its GTP-bound 
conformation. Also in support of this, an effector domain 
mutant analogous to a GAP-insensitive mutant of Yptlp 
(Becker et al., 1991), Rab5153M, which is phenotypically 
similar to Rab5Q79L (Stenmark et al., 1994a), activated 
the reporter gene severalfold higher than wild-type Rab5. 
Isoprenylation of Rab5 is not required for its interaction 
with the Ll-46 protein, since the Rab5ACCSN mutant, 
lacking the isoprenylation motif, activated /acZ even 
stronger than wild-type Rab5. All together, these results 
suggest that the Ll-46 clone encodes a protein that specifi- 
cally interacts with the GTP-bound, active form of Rab5. 
Rabaptin-5 Is a Hydrophilic Protein Containing Two 
Putative Coiled-Coil Regions 
A sequence database search showed that the DNA se- 
quence of Ll-46 is virtually identical to the 3’ region of 
the partial cDNA clone Hsupue (EMBL accession number 
X77723). Since this clone lacked a potential translation 
initiation codon, we screened a random-primed HeLa 
cDNA library with a probe representing the 5’ end of 
Hsupue. One clone was obtained that contained a 1.25 
kb insert that extended the Hsupue clone by 128 nt. This 
clone was found to contain a potential initiator ATG codon, 
which matches well the consensus sequences for transla- 
tional initiation (Kozak, 1987). A stop codon was found in 
the same reading frame upstream of this ATG. Further- 
more, the overexpressed protein had the same apparent 
size (115 kDa) in immunoblotting experiments as the en- 
dogenous protein (data not shown), indicating that the 
identified ATG does represent the start codon of the 
protein. 
Table 1. Interaction between Clone Ll-46 and Various LexA 
Fusions, Assayed as lacZ Reporter Gene Activity 
LexA Fusion Activation Domain 5-Galactosidase 
Fusion Activity (U) 
Rab5079L - 0.1 * 0.1 
- Ll -46 0.1 f 0.0 
Rab5 Ll-46 32.5 + 3.6 
Rab5ACCSN Ll-46 75.2 + 7.4 
Rab5S34N Ll-46 2.1 k 0.3 
Rab5153M Li -46 132 2 27 
Rab5Q79L Ll-46 203 f 58 
Rab4b Ll-46 0.4 f 0.1 
Rab6 Li-46 0.1 -c 0.0 
Rab6T27N Ll -46 0.1 2 0.0 
Rab6Q72L Ll -46 0.1 f 0.1 
Rabl7 Li -46 0.4 f 0.1 
Rab22 Ll-46 0.3 k 0.1 
RasG 12V Ll-46 0.2 f 0.1 
Lamin C Ll -46 0.1 f 0.1 
L40 reporter yeast cells transformed with the rescued Ll-46 plasmid, 
or with plasmrds encoding LexA fusions of the proteins indicated, or 
both, were grown to ODWa values of approximately 1.0 in synthetic 
medium lacking tryptophan, leucine, or both. f3-Galactosidase activity 
was then measured, by using o-nitrophenyl-j3-o-galactoside (Sigma) 
as a substrate (Guarente, 1983). p-Galactosidase activities (in relative 
units) are presented as mean values 2 SEM obtained with three inde- 
oendent transformants. 
Rab5 Effector Protein 
425 
Figure 2. Primary Structure of Rabaptin-5 
(A) cDNA and predicted amino acid sequence of rabaptind. The se- 
quence is available from GenBank. 
(6) Histogram indicating the probability of forming an a-helical coiled 
coil in rabaptin-5 as determined according to the Lupas algorithm (Lu- 
pas et al., 1991), with a window size of 28 residues. The y axis shows 
the computed probability (O-l) of a-helical coiled-coil formation, while 
the x axis indicates the amino acid number for rabaptin-5. 
The predicted protein sequence (Figure 2A) consists of 
862 amino acid residues and has a calculated M, of 99,366 
and a predicted pl of 4.8. The protein sequence is hydro- 
philic, with no potential signal sequence or membrane 
spanning regions. The positive clone, Ll-46, corresponds 
to the C-terminal part (residues 551-862) of the open read- 
ing frame. The N- and C-terminal regions are predicted 
to be mainly a-helical and contain heptad repeats charac- 
teristic of coiled-coil domains (Figure 2B). We term this 
protein rabaptin-5 (from the Greek word apto, meaning 
touch; the numbering refers to Rab5) to distinguish it from 
the Rab3A-interacting molecules rabphilin-3A (Shirataki 
et al., 1993) and Rabin3 (Brondyk et al., 1995), to which 
it bears no significant sequence similarity. With the BLAST 
and BEAUTY programs, the highest identity score was 
found with a Caenorhabditis elegans open reading frame 
of unknown function (CEFOl F1.4, EMBLlGenBank acces- 
sion number U13070). The C-terminal part (residues 493- 
862) of rabaptin-5 is 30% identical to this protein, and a 
31-residue segment (807-837) is 81% identical. Interest- 
ingly, the early endosome-associated protein EEA1 (Mu 
et al., 1995) was grouped together with these two proteins 
(26% identitywith rabaptind), and sowas Fabl (18% iden- 
tity), a phosphatidylinositol(4)phosphate 5-kinase impli- 
cated in vacuole transport in yeast (Yamamoto et al., 
1995). The significance of this similarity remains to be 
investigated. The weak similarity between the latter pro- 
teins and rabaptin-5 extends through most of their se- 
quences, but is most pronounced near their C-termini. The 
open reading frame of rabaptin-5 also contains a weak 
similarity to the coiled coil-containing tail domain of myo- 
sin heavy chain and related proteins. 
Rabaptin-5 Binds Directly to the GTP-Bound Form 
of Rab5 In Vitro 
The findings based on the two-hybrid system that GTPase- 
deficient mutants of Rab5 interact strongly with the 
C-terminus of rabaptin-5, whereas a mutant with preferen- 
tial affinity for GDP does not, suggest that rabaptin-5 inter- 
acts with Rab5 in its GTP-bound conformation. To confirm 
this biochemically, we also measured binding of bacteri- 
ally expressed recombinant rabaptin-5 to recombinant 
Rab5. For this purpose, we immobilized Rab5 on protein 
A-Sepharose beads preincubated with a monoclonal anti- 
body against the C-terminus of Rab5 (Bucci et al., 1994). 
The recombinant protein was then loaded either with GDP 
or with the slowly hydrolyzable GTP analog, GTPyS, and 
binding of recombinant rabaptin5 was measured. Consis- 
tent with the data from the two-hybrid system, rabaptin-5 
bound to GTPyS-loaded Rab5, but not to Rab5-GDP, indi- 
cating that binding of rabaptind to Rab5 is GTP-depen- 
dent (Figure 3A). Binding was, however, not quantitative, 
suggesting that the affinity between recombinant rabap- 
tin-5 and Rab5 is relatively low. These results nevertheless 
show that rabaptin-5 is capable of interacting directly with 
Rab5-GTP. 
Rabaptind Is Present in Membrane and Cytosol 
Fractions and Is Expressed in Various Cell Types 
To address the function of rabaptind, we raised antisera in 
rabbits against the C-terminal region of rabaptind (Ll-46) 
expressed in Escherichia coli. The antisera were affinity- 
purified and were first characterized by immunoblot analy- 
sis. In agreement with the predicted molecular mass of 
rabaptind, the affinity-purified antibody recognized a sin- 
gle species of 115 kDa (Figure 3B). Given the ubiquitous 
expression of Rab5 (Chavrier et al., 1990) and its ability 
to regulate endocytosis in various cell types (Bucci et al., 
1992,1994; de Hoop et al., 1994), one would expect rabap- 
tin-5 also to be ubiquitously expressed if it were a true 
downstream effector of Rab5. We therefore examined by 
immunoblotting its expression in seven different human 
cell lines, derived from various organs. As shown in Figure 
3B, rabaptin-5 is expressed in all the cell lines tested, with 
HEp2 cells exhibiting the highest expression. 
Fractionation of HeLa and HEp2 cells (Figure 3C) 
showed that rabaptin5 is mainly cytosolic, whereas a mi- 
nor fraction (8% in HeLa cells and 10% in HEp2 cells) is 
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Figure 3. Binding of Recombinant Rabaptin-5 to Rab5 In Vitro and 
lmmunoblot Analysis of Rabaptin-5 in Human Cell Lines 
(A) Aliquots of protein A-SepharoseCL4B (Pharmacia) beads con- 
taining Rab5 immobilized via an anti-Rab5 monoclonal antibody, 4F11, 
were incubated with 100 PM GDP (lanes 1 and 3) or GTPrS (lanes 2 
and 4). Subsequently, beads were incubated in the presence of 0.5 
pg of Hi%-rabaptin-5. After washing, rabaptind associated with the 
beads was detected by SDS-PAGE followed by immunoblotting. 
(6) Total extracts (approximately 50 wg of protein) of the following 
human cell lines were analyzed by SDS-PAGE and immunoblotting 
with anti-rabaptin5. Lane 1, HeLa(cervical carcinoma); lane 2, HepGll 
(hepatocellular carcinoma); lane 3, CaLu (squamous cell lung carci- 
noma); lane 4, HEp2 (laryngeal carcinoma); lane 5, A431 (epidermoid 
carcinoma); lane 6, BeWo (choriocarcinoma); lane 7, Caco-2 (colonic 
adenocarcinoma). 
(C) HeLa (lanes 2-4) and HEpP cells (lanes 5-7) were fractionated 
into high speed pellet(M) and supernatant (C). Proportional amounts 
of supernatant (20 pg, lanes 3 and 6) and pellet (12 wg, lanes 4 and 
7) were analyzed by SDS-PAGE followed by immunoblotting using 
affinity-purified anti-rabaptin-5 (upper part) and 2A4 monoclonal anti- 
Rab5 antibodies (lower part). Postnuclear supernatants (32 pg. lanes 
2 and 5) and recombinant Hi%-rabaptin-5 (10 ng, lane 1) and Rab5 
(10 ng, lane 6) were analyzed as controls. 
membrane bound. The significance of the membrane- 
associated rabaptind will be discussed in the following 
sections. Unlike rabaptin-5, flab5 was found mostly in the 
membrane fraction (82% in HeLa and 83% in HEp2 cells). 
We estimated that HeLa cells contain 0.9 pmol rabaptind 
and 0.5 pmol Rab5 per milligram of postnuclear superna- 
tant, whereas the values for HEp2 cells are 1.7 and 1.9 
pmol, respectively. The apparent correlation between 
Rab5 and rabaptin-5 expression in these cell lines is in line 
with the idea that rabaptin-5 is involved in Rab5 function. 
Rabaptin-5 Colocalizes with Rab5Q79L 
on Endosomal Membranes, and its Overexpression 
Alters Endosome Morphology 
We next examined the intracellular localization of rabap- 
tin-5. First, we coexpressed its Myc epitope-tagged C-ter- 
minus, Ll-46, with Rab5 mutants in BHK cells and studied 
the localization of the two proteins by confocal immunoflu- 
orescence microscopy. We permeabilized the cells with 
saponin prior to fixation, to wash out the excess of exoge- 
nous cytosolic protein. Expression of the Rab5Q79L mu- 
tant causes the expansion of the early endosome compart- 
ment (Figure 4A’), whereas expression of the Rab5S34N 
mutant induces its fragmentation (Figure 48’). Using anti- 
Rab5 and anti-Myc epitope antibodies, we observed exten- 
sive membrane colocalization between Rab5Q79L and 
Myc-Ll-46 (Figures 4A and 4A’), but little binding of Myc- 
Ll-46 on endosomes expressing Rab5S34N (Figures 48 
and 4B’). Similar results were obtained when full-length 
rabaptind was expressed (data not shown). These find- 
ings are consistent with the restricted binding of rabaptind 
to Rab5-GTP both in the two-hybrid system and in vitro 
(see Figures 1 and 3A; Table 1). 
To determine the intracellular localization of the endoge- 
nous protein, we used the affinity-purified antibody against 
the C-terminal part of rabaptin-5 and a stably transfected 
HeLa cell line that expresses a very low level of Myc- 
tagged Rab5Q79L (Stenmark et al., 1994a). As shown in 
Figure 4C, the anti-rabaptin-5 antibody gave a diffuse im- 
munofluorescence staining throughout the cytoplasm, 
most likely representing cytosolic protein, in agreement 
with the subcellular fractionation experiments in Figure 
3C. Interestingly, however, rabaptind was also found on 
membrane structures, where it colocalized with Myc- 
Rab5Q79L (see arrowheads in Figure 4C’ and overlay in 
Figure 4C”). The increased membrane association of ra- 
baptind in HeLa cells overexpressing Rab5Q79L was also 
confirmed by Western blot analysis (data not shown). 
Overexpression of Rab5 and Rab5Q79L results in a 
characteristic expansion of the early endosome compart- 
ment (Bucci et al., 1992; Stenmark et al., 1994a). Assum- 
ing that rabaptin-5 is involved in Rab5 function, we investi- 
gated whether its overexpression is sufficient to cause a 
similar effect. Indeed, overexpression of rabaptind (Fig- 
ure 4D) led to changes of transferrin receptor-positive 
structures (4D’), reminiscent of those observed upon Rab5 
overexpression (Bucci et al., 1992), almost as striking as 
those induced by the Rab5Q79L mutant protein (Stenmark 
et al., 1994a) (compare with Figure 4A). This effect re- 
quired the full-length rabaptin-5 protein and was not ob- 
served upon overexpression of its C-terminal part alone 
(data not shown). 
As for the exogenously expressed protein (Figures 4D, 
4D’, and 4D”), endogenous rabaptind was also found to 
colocalize partially with the transferrin receptor (data not 
shown). Since this receptor is both endocytosed and recy- 
cled, we also checked whether rabaptind is associated 
with the para-Golgi recycling compartment (Yamashiro et 
al., 1984; Hopkinset al., 1994). Surface-bound fluorescein 
isothiocyanate (FITC)-transferrin, internalized for 30 min 
at 37% to label this compartment selectively (4E), did not 
colocalize with rabaptind to a detectable extent, sug- 
gesting that rabaptin-5 is not involved in the recycling path- 
way. Furthermore, we did not detect colocalization be- 
tween rabaptin-5 and the endoplasmic reticulum marker 
protein disulfide isomerase (PDI, 4F), and epitope-tagged 
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Figure 4. Confocal lmmunofluorescence Anal- 
ysis of Cells Expressing Endogenous or High 
Levels of Rabaptind 
(A) BHK cells cotransfected with Myc-Ll-46 
and RabW79L. 
(B) BHK cells cotransfected with Myc-Li-46 
and Rab5S34N. The cells were permeabilized 
with saponin prior to fixation and were stained 
with anti-Myc 9ElO monoclonal (Evan et al., 
1985) (A, B) and anti-Rab5 affinity-purified poly- 
clonal (Chavrier et al., 1990) (A’, 8’) antibodies. 
(C) HeLa 4-4-7-7 cells, which express a low 
level of Myc-Rab5-Q79L, were stained with 
anti-rabaptind (C) and anti-Myc (C’) antibod- 
ies. Arrowheads indicate representative exam- 
ples of membrane structures in the cell periph- 
ery where rabaptin-5 and the Rab5 mutant 
colocalize. 
(D) HeLa cells transfected with full-length ra- 
baptin-5 were stained with anti-rabaptin-5 (D) 
and anti-human transferrin receptor (B3/25; 
Boehringer Mannheim) antibodies (D’). In (D), 
a transfected cell overexpressing rabaptin-5 is 
visible, displaying larger endosomes than 
those present in the nearby untransfected 
cells. 
(E) FITC-transferrin (20 pglml) was bound to 
HeLa cells for 60 min on ice. The cells were 
then washed with PBS, and the FITC-transferrin 
(green) was internalized for 30 min at 37% in 
the presence of 5 mM nitrilotriacetic acid. Red 
color indicates anti-rabaptin-5 staining. 
(F) HeLa cells were double-labeled with anti- 
rabaptind (red) and anti-PDI (green). 
(G) HeLa cells transfected with epitope-tagged 
sialyl transferase were stained with anti- 
rabaptin-5 (red) and anti-epitope (XV-G)-tag 
(green) antibodies (P5D4; Kreis, 1986). 
The cells in (C)-(G) were fixed prior to permea- 
bilization. Overlays are shown in (A”), (B”), (C”), 
(D”), (E), (F), and (G), with yellow color indicat- 
ing colocalization and red color indicating ra- 
baptind. Coverslips were viewed with the 
EMBL confocal microscope, as described 
(Bucci et al., 1992). 
Scale bar, 10 Km. Bar in (A) also applies for 
(B), 0, (E), UT, and (G). 
sialyl transferase (4G), a Golgi and trans-Golgi network 
marker, suggesting that its localization to RabS-positive 
early endosome membranes is specific. 
Rabaptin-5 Is Recruited by Rab5 to Early Endosome 
Membranes in a GTP-Dependent Manner 
The overexpression studies suggested that rabaptind is 
a component of the early endosome fusion machinery. 
Given the requirement for flab5 in early endosome fusion 
(Gorvel et al., 1991), we determined whether flab5 could 
Capture cytosolic rabaptin-5 on an early endosome-en- 
riched membrane fraction. Rab GDP dissociation inhibitor 
(GDI)-mediated association of Rab5 with membranes does 
not require other cytosolic factors and is accompanied by 
nucleotide exchange (Ullrich et al., 1994). When an early 
endosome-enriched fraction was incubated in the pres- 
ence of increasing amounts of Rab5-GDI complex and 
1 mM GDP, a dose-dependent increase in early endo- 
some-associated flab5 was detected (Figure 5) in 
agreement with previous studies with permeabilized cells 
(Ullrich et al., 1994). However, the membrane association 
of RabS-GDP was not accompanied by a concomitant 
increase in membrane-associated rabaptin-5. In contrast, 
when incubation was done both in the presence of 1 mM 
GTP and different amounts of Rab5-Rab GDI complex, 
the membrane association of Rab5 was paralleled by a 
strong, dose-dependent increase in membrane-bound ra- 
baptind. Recruitment was maximal at 25 nM Rab5-Rab 
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Figure 5. Rab5- and GTP-Dependent Binding of Rabaptind to Early 
Endosomes 
Aliquots of early endosome-enriched fractions prepared by using a 
flotation gradient as described in Experimental Procedures were incu- 
bated in the presence of various concentrations of Rab5-Rab GDI 
complex and HeLa cell cytosol in the presence of either 1 mM GDP 
or 1 mM GTP. After high-speed centrifugation, the membranes were 
solubilized in SDS sample buffer, and the fraction of Rab5 and rabap- 
tin-5 was determined by immunoblot analysis. Values were de!ermined 
by densitometric scanning of fluorographs. Error bars represent the 
range between two independent experiments. 
GDI complex and did not proportionally increase with 
higher concentrationsof membrane-bound Rab5. The sig- 
nificance of this remains to be investigated, but suggests 
that some other membrane component is limiting for bind- 
ing of rabaptin-5 to the membrane. Interestingly, addition 
of 1 mM GTP, even in the absence of exogenous Rab5- 
Rab GDI complex, led to a low but significant increase 
in membrane-bound rabaptin-5, presumably reflecting the 
binding activity of endogenous Rab5. That the membrane 
association of rabaptin 5 is specific for Rab5-containing 
endosomes was suggested by the observation that micro- 
somes fail to bind exogenous Rab5 and, consequently, 
do not recruit cytosolic rabaptind (data not shown). Collec- 
tively, these data show that membrane association of ra- 
baptind is both Rab5- and GTP-dependent, and we con- 
clude that Rab5 serves to recruit cytosolic rabaptind to 
membranes. 
Also, recombinant His,-rabaptind, added at a similar 
concentration as that of cytosolic rabaptind, was found 
to bind to early endosomes, even in the absence of cytosol. 
The binding was 3-fold higher in the presence of RabS- 
GTP than in the presence of RabS-GDP, suggesting also 
that the recombinant protein binds in a specific way (data 
not shown). However, binding of His+rabaptin& was only 
10% compared with that of cytosolic rabaptind, and at 
high concentrations, His,-rabaptin-5 appeared to bind to 
endosomes in a nonspecific manner. The reason for this 
is not clear, but perhaps some of the purified recombinant 
protein is incorrectly folded, or additional cytosolic factors 
are required for optimal binding of rabaptin-5 to RabS- 
containing endosomes (see Discussion). 
Rabaptin-5 Is Required for RabS-Stimulated Fusion 
between Early Endosomes in a Cell-Free System 
We next tested the function of rabaptin-5 in a cell-free 
assay of homotypic fusion between early endosomes, 
which is based on the detection of complex formation be- 
tween internalized avidin in one endosome fraction and 
biotinylated horseradish peroxidase (bHRP) in the other. 
Such fusion is cytosol- and ATP-dependent (Diaz et al., 
1988; Gruenberg and Howell, 1988) and requires Rab5 
(Gorvel et al., 1991). To investigate the requirement for 
rabaptin-5 in the fusion reaction, the protein was immuno- 
depleted from the cytosol. lmmunoblot analysis (Figure 
6A, lane 3) demonstrated that -90% of rabaptin-5 was 
immunodepleted under the conditions used. As shown in 
Figure 6B, mock depletion of the cytosol with preimmune 
serum did not affect fusion. However, depletion with pro- 
Rabaptin-5 
- 
RabS-GDI + RabS-GDI 
7 
Figure 6. ImmunodepletionofRabaptin-5fromCytosol InhibitsFusion 
between Early Endosomes In Vitro 
(A) Aliquots of 100 pg of HeLa cytosol, diluted to 50 pl in early endo- 
some fusion buffer, were incubated with the indicated amounts of 
anti-rabaptin-5 antibodies immobilized onto 10 ~1 of protein A-Sepha- 
rose CL4B beads (see Experimental Procedures). Beads were then 
pelleted, and the supernatants were subjected to SDS-PAGE and 
immunoblotting with anti-rabaptin-5 antibodies. 
(8) Fusion of avidin and bHRP-labeled early endosome fractions was 
determined as described in Experimental Procedures. In vitro fusion 
was carried out in the absence (lanes l-3) or presence (lanes 4-8) of 
25 nM Rab5-Rab GDI complex. For the immunodepletion of rabaptin-5 
from cytosol, we used beads preincubated with preimmune serum, 
anti-rabaptin-5 serum, or affinity-purified anti-rabaptind antibodies, as 
described in Experimental Procedures. Lanes 1 and 4, control reac- 
tions; lanes 2 and 5, reactions in the presence of cytosol preincubated 
with preimmune serum; lanes 3 and 6, cytosol preincubated with anti- 
rabaptind serum: lane 7, cytosol preincubated with affinity-purified 
anti-rabaptin-5 antibodies; lane 8, as in lane 6 but using anti-rabaptin-5 
beads preincubated with 4 pM of Ll-46Cterminal rabaptindfragment. 
The result of a typical experiment is shown, where each value repre- 
sents the mean of duplicate samples, which differed by <lo%. 
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tein A-Sepharose beads preincubated with anti-rabaptin-5 
serum significantly inhibited fusion (600/o), suggesting that 
rabaptind is required for this process. 
Early endosome fusion is strongly stimulated by post- 
translationally modified Rab5 (Gorvel et al., 1991; Li et al., 
1994b). Previous studies have shown that Flab GDI and 
Rab escort protein (REP) are capable of delivering Rab5 
to the correct compartment in its geranylgeranylated form 
(Alexandrov et al., 1994; Ullrich et al., 1994). As already 
shown for REP-Rab5 complex, addition of Rab GDI-Rab5 
complex to the reaction stimulated fusion by approxi- 
mately 140%. Mock-depleted cytosol stimulated fusion 
to the same extent as untreated cytosol in the presence 
of Rab GDI-Rab5 complex. In contrast, the stimulation 
of early endosome fusion induced by Rab5 was totally 
abrogated when rabaptin-5-depleted cytosol was used in 
the assay (Figure 66). The reason why early endosome 
fusion was not completely inhibited underthese conditions 
may be that the excess of Rab5 on the membrane effi- 
ciently recruits the rabaptin-5 remaining after immunode- 
pletion. Early endosome fusion activity could be com- 
pletely rescued by preincubating the antibody in the 
presence of recombinant rabaptin-5 expressed in E. coli. 
Altogether, these results demonstrate that rabaptin-5 is 
required for Rab5dependent homotypic fusion between 
early endosomes. 
Discussion 
We have previously established that the small GTPase 
Rab5 plays a central role in the regulation of early endo- 
cytic traffic (Gorvel et al., 1991; Bucci et al., 1992). In this 
paper, we report the identification of rabaptin-5, a novel 
100 kDa predicted coiled-coil protein that interacts specifi- 
cally with Rab5. Rabaptin-5 is ubiquitously expressed and 
is present in a major cytosolic and a minor endosome- 
bound pool. Several lines of evidence show that Rab5 
exerts its regulatory function through rabaptin-5. First, ra- 
baptin-5 binds directly to Rab5 and preferentially to its 
GTP-bound form. Second, it is recruited to early endo- 
somes by Rab5 in a GTP-dependent manner. Third, its 
overexpression leads to morphological alterations of the 
early endosome compartment similar to those induced by 
Rab5. Fourth, its depletion from cytosol blocks Rab5 func- 
tion. Rabaptin-5 is, therefore, an effector of Rab5 that 
transmits the signal of the GTP-bound active conformation 
to the membrane docking and/or fusion apparatus. 
The molecular machinery of vesicle targeting and fusion 
is beginning to be unraveled. According to the SNARE 
hypothesis (Sollner et al., 1993), specificity in vesicle fu- 
sion is conferred by correct pairing of V-SNARES on vesicle 
membranes with t-SNARES on target membranes. On the 
basis of genetics in yeast, Rab GTPases have been pro- 
posed to ensure directionality by cyclically regulating the 
partnering of cognate SNARES (Novick and Brennwald, 
1993; Zerial and Stenmark, 1993; Rothman, 1994). How- 
ever, all biochemical attempts carried out so far to incorpo- 
rate Rab proteins into the SNARE-mediated vesicle dock- 
ing complex have failed. Besides trivial technical reasons, 
an alternative possibility is that these two classes of pro- 
teins do not interact directly (Scheller, 1995). If this were 
the case, specificity of membrane traffic would not be ex- 
plained in terms of these proteins alone. Additional pro- 
teins would be required, and we believe that rabaptin-5 
represents a factor contributing to the specificity in endo- 
cytic membrane interactions. 
The concept emerging from this study, that Rab5 serves 
as a regulatable membrane anchor for rabaptin-5, has its 
precedent in the cases of other small GTPases. Ras-GTP 
causes the cytosolic protein kinase Raf to translocate to 
the plasma membrane, where it is activated and initiates 
a phosphorylation cascade (Vojtek et al., 1993). Further- 
more, the cytosolic kinases ACK and PAK (Manser et al., 
1993,1994) associate with the GTP-bound forms of certain 
members(MmCdc42and Racl)of the Rho GTPasefamily. 
Sarl and Arfl proteins also regulate the recruitment of 
coat proteins from the cytosol on the membrane of nascent 
budding vesicles (Barlowe et al., 1994; Ostermann et al., 
1993; Stamnes and Rothman, 1993). Our data thus sug- 
gest that the function of recruiting acytosolic target applies 
also to Rab proteins as a common theme in the function 
of many small GTPases. Rab3A and Rab3C have been 
proposed to recruit rabphilin3A to the synaptic vesicle 
membrane, since in neurons lacking both these proteins, 
rabphilin-3A is found in the cell body (Li et al., 1994a). On 
the other hand, treatment of synaptic vesicles with Rab 
GDI, which solubilizes Rab proteins, did not affect mem- 
brane association of rabphilin-3A, suggesting that also 
other molecules than Rab3AIRab3C may be involved in 
the membrane recruitment of this protein (Shirataki et al., 
1994). The lack of similarity between rabphilin3A and ra- 
baptind implies that these proteins have distinct func- 
tions, and perhaps rabphilin-3A, which contains calcium- 
and phospholipid-binding C2 domains, represents a class 
of molecules that is restricted to regulated secretion. 
On the basis of the in vitro studies that document the 
sequential attachment of Rab5 and rabaptin-5 to the mem- 
brane, we propose the following model for Rab5 function. 
RabS-GDP, complexed either with Rab GDI or REP in 
the cytosol, associates with its acceptor membranes in 
a cytosol-independent manner (Alexandrov et al., 1994; 
Ullrich et al., 1994). Following release of its cytosolic car- 
rier, Rab5 in its GDP-bound, inactive form is converted 
by a membrane-bound GEF into the GTP-bound confor- 
mation (Horiuchi et al., 1995; Ullrich et al., 1994). Once 
activated, GTP-bound Rab5 then recruits on the mem- 
brane its effector protein, rabaptin-5, from the cytosol. Ra- 
baptin-5 thereby becomes correctly positioned to exert its 
function in membrane docking or fusion. Finally, upon 
GTP hydrolysis (Stenmark et al., 1994a), rabaptind is re- 
leased into the cytosol, and the GDP-bound Rab5 is re- 
moved from the membrane by the action of Rab GDI (UII- 
rich et al., 1993). The recruitment of a cytosolic effector 
protein only after GDP/GTP exchange, and only at the 
correct membrane, ensures a temporal and spatial control 
of membrane-membrane interactions. 
What is the function of rabaptind? One possibility is 
that rabaptin-5 binds to a receptor molecule at the target 
membrane and thereby promotes vesicle docking. Alter- 
natively, rabaptin-5 might interact with SNARES that also 
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display coiled-coil domains(Rothman, 1994). A third possi- 
bility would be that the coiled-coil regions, rather than in- 
teracting directly with SNARES, could be involved in the 
formation of complexes with other molecules, acting up- 
stream of SNARES. This would explain why Rab function 
appears necessary for the pairing of SNARES, yet Rab 
proteins cannot be detected in the SNARE complex (Lian 
et al., 1994; S@gaard et al., 1994). Consistent with the 
latter hypothesis, preliminary fractionation data indicate 
that, following separation of cytosol by gel filtration chro- 
matography, rabaptind elutes as a multiprotein complex. 
Sec2p, SecGp, Sec8p, and Secl5p, four yeast proteins 
that interact genetically with, and are potential down- 
stream effecters of, the Rab homolog Sec4p (Goud et 
al., 1988), are also found mainly in the cytosol as parts of 
high M, complexes (Nair et al., 1990; TerBush and Novick, 
1995). These data raise the exciting possibility that Rab5 
may recruit rabaptin5 as part of a large cytosolic particle, 
possibly containing one or more homologs of these mole- 
cules. Assuming that several Rab proteins may share the 
same principle of action, our model would predict the exis- 
tence of a family of rabaptin-5related molecules impli- 
cated in intracellular transport. 
The organization of the endosomal compartment is still 
under investigation. Receptors are internalized from the 
surface into endosomes consisting of vacuoles, cisternae, 
and tubules. From here they can be routed back to the 
plasma membrane, passing through a tubular recycling 
compartment in the para-Golgi region (Yamashiro et al., 
1984; Hopkins et al., 1994). Since overexpression of Rab5 
(Bucci etal., 1992)and Rab5Q79L(Stenmarketal., 1994a) 
causes the expansion of the vacuolar part of the early 
endosomes, we suggest that Rab5 and rabaptin-5 act at 
this level. In addition, rabaptind does not appear to be 
associated with the recycling compartment and therefore 
must regulate traffic prior to this step, consistent with the 
function of Flab5 in the early steps of endocytosis (Bucci et 
al., 1992). The identification of rabaptind described here 
provides the basis for further work aimed at elucidating the 
molecular mechanism of the docking and fusion process in 
membrane transport. 
Experimental Procedures 
Plasmids 
pLexA-Rab5, pLexA-Rab5S34N, pLexARab5Q79L, pLexA-Rab5A- 
CCSN, pLexA-Rab4b, pLexA-Rab17, and pLexA-Rab22 were obtained 
by cloning Rab DNAs from the respective pGEM-1 constructs (Chavrier 
et al., 1990; Lutcke et al., 1993; Olkkonen et al., 1993; Stenmark et 
al., 1994a) into the polylinker sites of pBTMl16 (Vojtek et al., 1993). 
The pLexA-Rab6 constructs were from I. Janoueix-Lerosey and B. 
Goud, and the pLexA-RasGl2V and pLexA-Lamin C constructs were 
from A. Vojtek (Vojtek et al., 1993). pHEA1368 was from W. Northem- 
ann. pGEM-UEP was constructed by polymerase chain reaction (PCR) 
amplification of clone l-VI (see below) using the primers ATTACcATG- 
GCGCAGCCGGGC and AGCCTAAGGTGGAACTGG, followed by 
cloning of a 260 bp Ncol-Sspl fragment from the PCR product and a 
2600 bp Sspl-Pstl fragment from pHEA1368 into a pGEM-1 vector 
engineered to contain a Ncol site upstream of the Pstl site. pHAT-UEP 
wasobtainedbycloninga2.76kbNcol-PstlfragmentfrompGEM-UEP 
into the Ncol-Nsil sites of pHAT-1. pGEM-Myc-Ll-46 was constructed 
by placing the 2.6 kb EcoRI-Xhol insert of clone Ll-46 behind the 
epitope for the monoclonal anti-Myc antibody 9ElO (Evan et al., 1985) 
in pGEM-1. 
Two-Hybrid Screening 
The yeast reporter strain L40 (Vojtek et al., 1993) (MATa frpl leu2 
his3 LYS2::lexA-HIS3 UFfAS::lexA-/acZ) was transformed with pLexA- 
Rab5Q79L by using a lithium acetate-based method (Schiestl and 
Giest, 1989) and grown on synthetic medium lacking tryptophan. This 
transformant was then transformed with library DNA (MATCHMAKER 
HeLa cell oligo(dT)-primed library in pGAD GH, Clonetech). The trans- 
formants were grown for 8 hr in synthetic medium lacking tryptophan 
and leucine and plated on synthetic medium lacking histidine, leucine, 
tryptophan, uracil, and lysine. Colonies were picked 4.5 days after 
plating and tested for b-galactosidase activity, by use of a replica filter 
assay (Vojtek et al., 1993). Library plasmids from positive clones were 
rescued into E. coli HB101 cells plated on leucine-free medium and 
subsequently analyzed by transformation tests and DNA sequencing. 
Cloning of the 5’ Region of Rabaptin-5 cDNA 
A randomly primed HeLa cell cDNA library (1.5 x IO” colonies) in the 
plasmid vector pUEX (Bressan and Stanley, 1987) was screened with 
a3’P-labeled DNA probe obtained by random-primed labeling of a 450 
bp EcoRI-Xmnl fragment of pHEA1368, corresponding to the very 5 
end of the partial cDNA clone Hsupue. Of 16 positive clones obtained, 
restriction mapping and sequencing showed that clone l-VI extended 
the original cDNA by 128 bp toward the 5’end and was found to contain 
a possible initiator ATG codon at position 189 and a stop codon in 
the same reading frame at position 64. 
Cells and Transfection 
HeLa 4-4-7-7 is a subclone of HeLa 4-4-7 cells, which express Myc- 
Rab5079L at a level lower than that of endogenous Rab5 (Stenmark 
et al., 1994a). HeLa transfectants expressing epitope-tagged sialyl 
transferase have been described by Rabouille et al. (1995). For tran- 
sient overexpression studies, BHK-21 or HeLa cells were infected for 
30 min with T7 RNA polymerase recombinant vaccinia virus (vT7) 
and then transfected with pGEM-1 plasmids containing the cDNA of 
interest, by use of DOTAP (Boehringer, Mannheim), as described 
(Stenmark et al., 1995). 
Confocal lmmunofluorescence Microscopy 
Cells on 11 mm round glass coverslips were fixed with 3% paraformal- 
dehyde. In some cases, the cells were permeabilized with 0.05% sapo- 
nin (Sigma) prior to fixation, whereas in other cases, the cells were 
permeabilized with 0.1% Triton X-100 after fixation. Free aldehyde 
groups were quenched with 50 mM NH&I, and the fixed cells were 
incubated with primary antibodies, as described previously(Stenmark 
et al., 1994b). As secondary antibodies, we used rhodamine- or FITC- 
conjugated donkey antibodies against mouse or rabbit IgG (Jackson 
Immunoresearch). Coverslips were mounted on Mowiol (Hoechst) and 
examined in the European Molecular Biology Laboratory (EMBL) 
confocal microscope, at the excitation wavelengths of 476 nm and 
529 nm. 
Recombinant Proteins 
BL-21 (DE3) E. coli cells, transformed with pRSET-Ll-46 or pHAT- 
UEP, were incubated for 3 hr at 37°C in the presence of 0.3 mM IPTG 
to induce expression of the Hiss-tagged proteins. The proteins were 
purifiedon Ni’+-agarose(Quiagen), according tothe native purification 
protocol from the manufacturer, followed by ion-exchange chromatog- 
raphy on a Mono Q FPLC column (Pharmacia). By this purification, 
Hiss-Ll-46 was >95% pure, and Hiss-rabaptin-5 was >70% pure. 
In Vitro Binding Studies with Recombinant Proteins 
Aliquots (10 nl) of protein A-SepharoseCL4B(Pharmacia) were prein- 
cubated for 20 min at room temperature with 1 ug of the anti-Rab5 
monoclonal antibody 4Fll (Bucci et al., 1994) in buffer A (20 mM 
HEPES [pH 7.21, 100 mM NaCI, 0.5 mM MgCI;., 2 mM EDTA, and 1 
mM dithiothreitol), then washed and incubated with buffer A in the 
absence and presence of 0.2 ug of HissRab5 for 30 min at room 
temperature. The beads were then washed and incubated with 100 
NM GDP or GTPyS in buffer A, at 30°C for 30 min. Subsequently, 20 
mM MgCI, and 0.5 pg of His&abaptin-5 were added, and incubation 
at 30°C continued for 30 min. Finally, the beads were washed three 
times with ice-cold buffer A containing 20 mM MgCb. Rabaptind asso- 
ciated with the beads was detected by SDS-polyacrylamide gel elec- 
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trophoresis (PAGE) followed by immunoblotting, using affinity-purified 
anti-rabaptind rabbit polyclonal antibodies raised against recombi- 
nant Hiss-Li-46 protein and the ECL kit from Amersham. 
Cell Fractionation and lmmunoblot Analysis of Rabaptin-5 
HeLa cells grown to confluence in four Costar plates (9 cm) were 
scraped into PBS, then pelleted and homogenized in 400 PI of 250 
mM sucrose, 3 mM imidazole (pH 7.2) by five passages through a 22 
gauge canule. Nuclei and debris were pelleted by centrifugation at 
4000 rpm for 5 min in an Eppendorf centrifuge. The postnuclear super- 
natant was centrifuged at 60,000 rpm for 30 min at 4% in a Beckmann 
TLA-100 rotor, and aliquots of the pellet and supernatant fractions 
were analyzed by SDS-PAGE followed by immunoblotting. 
Binding of RabC and Rabaptin-5 to Early 
Endosome-Enriched Fractions 
Early endosome-enriched fractions were prepared as described (Gor- 
vel et al., 1991). For the recruitment of rabaptin-5 on early endosome 
membranes, aliquots of early endosome-enriched fractions (28 Kg) 
were incubated in the presence of various concentrations of Rab5- 
Rab GDI complex and 300 trg of HeLa cell cytosol (dialyzed against 
250 mM sucrose, 3 mM imidazole [pH 7.41) in the presence of either 
1 mM GDP or 1 mM GTP for 15 min at 37OC. In some cases, 50 ng 
of Hiss-rabaptin-5 was added to the earlyendosome-enriched fraction. 
Rab5-Rab GDI complex was prepared in fusion buffer (12.5 mM 
HEPES-KOH, 1 mM dithiothreitol, 2 mM Mg-acetate, and 75 mM 
K-acetate [pH 7.21) containing 1 pM GDP and 0.005% Triton X-100, 
according to the protocols of Ullrich et al. (1995). As controls, we also 
used dog pancreas microsomes (28 Kg). To reduce the sucrose con- 
centration, samples were diluted 4 x in fusion buffer, and after high 
speed centrifugation, the membranes were solubilized in SDS sample 
buffer, and the fraction of Rab5 and rabaptind was determined by 
immunoblot analysis using the 2A4 monoclonal anti-Rab5 (Bucci et 
al., 1994) and affinity-purified anti-rabaptin-5 antibodies. Hiss-rabaptin-5 
was detected with an anti-Hiss tag antibody (DiaNova). Values were 
determined by densitometric scanning of fluorographs using NIH Im- 
age 1.55 (National Institutes of Health). 
Cell-Free Assay of Early Endosome Fusion 
For the fusion assay, avidin and bHRP were internalized separately 
into two cell populations for 5 min, and early endosome-enriched frac- 
tions were prepared (Gorvel et al., 1991). Fusion of avidin and bHRP- 
labeled early endosome fractions was measured in the presence of 
HeLa cytosol (4 mglml) and ATP-regenerating system for 45 min at 
37%. The avidin-bHRP complexes formed upon fusion were immuno- 
precipitated, and the extent of fusion was quantified with the Immuno- 
Pure detection liquid (Pierce, Rockford, Illinois). For the immunodeple- 
tion, we used protern A-Sepharose CL46 beads preincubated for 60 
min at 4% with 0.5 ~1 of preimmune serum, 0.5 VI of anti-rabaptin-5 
serum, or 0.5 trg of affinity-purified anti-rabaptind antibody per 100 
trg of cytosol. The beads were washed extensively with fusion buffer 
and subsequently incubated with cytosol for 30 min at 4%. After cen- 
trifugation at 14,000 x g for 5 min, the supernatant was used in the 
fusion assay. Rescue of fusogenic activity was performed by preincu- 
bating the antibodies bound to the beads with 4 PM Ll-46 recombinant 
protein for 1 hr at 4%. The beads were then washed to remove un- 
bound Ll-46 and incubated with cytosol as described above. 
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